+44(0)208 9952500 karen.stancombe@lionsdencommunications.com LionsDen Communications Lionsden medical John Clare

Targeted drugs offer hope

At ASCO in Chicago working with a client whose #lungcancer drug has just reported an increase of over a year in Overall Survival…if you have a particular genetic mutation.  More evidence of the growing influence and application of targeted treatment in cancer. It also shows how accurate diagnostic testing and the search for  predictive biomarkers are as important as the drugs themselves.  I guess this is one part of the answer to my question yesterday about how things have changed since the first #ASCO 50 years ago.

  • LinkedIn
  • Twitter
  • Facebook
  • StumbleUpon
  • Tumblr
  • Google Bookmarks
Leave a Reply

There are currently no comments.